[HTML][HTML] Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology

M Cisło, AA Filip, GJA Offerhaus, B Ciseł… - Oncotarget, 2018 - ncbi.nlm.nih.gov
In Western countries the majority of gastric cancers (GC) are usually diagnosed in advanced
stages reporting a 5-year survival rate of only 26%. The Laurén classification of GC was …

Surgery matters: progress in surgical management of gastric cancer

K Beyer - Current Treatment Options in Oncology, 2023 - Springer
Opinion statement The surgical treatment of gastric carcinoma has progressed significantly
in the past few decades. A major milestone was the establishment of multimodal therapies …

[HTML][HTML] S3-Leitlinie Magenkarzinom–Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs–Langversion 2.0–August …

M Moehler, SE Al-Batran, T Andus… - Zeitschrift für …, 2019 - thieme-connect.com
In dieser Leitlinie sind eingetragene Warenzeichen (geschützte Warennamen) nicht
besonders kenntlich gemacht. Es kann also aus dem Fehlen eines entsprechenden …

Current surgical treatment standards for esophageal and esophagogastric junction cancer

MK Jung, T Schmidt, SH Chon… - Annals of the New …, 2020 - Wiley Online Library
A number of different surgical techniques for the treatment of cancer of the esophagus and
the esophagogastric junction have been proposed. Guidelines generally recommend a …

True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends

T Kumamoto, Y Kurahashi, H Niwa, Y Nakanishi… - Surgery Today, 2020 - Springer
The definition of true esophagogastric junction (EGJ) adenocarcinoma and its surgical
treatment are debatable. We review the basis for the current definition and the Japanese …

Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

TO Goetze, RD Hofheinz, T Gaiser… - … Journal of Cancer, 2023 - Wiley Online Library
This multicenter, randomized phase II/III study evaluated the addition of the vascular
endothelial growth factor receptor‐2 inhibitor ramucirumab to FLOT as perioperative …

Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E= G and GE cancers

AH Hölscher, S Law - Gastric Cancer, 2020 - Springer
For Siewert type II adenocarcinoma of the esophagogastric junction (AEG II), or similar
tumors classified as Nishi EG, E= G, GE, the type of surgical resection and reconstruction …

Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors

S Mine, Y Kurokawa, H Takeuchi, K Kishi, Y Ito… - European Journal of …, 2015 - Elsevier
Background The optimal surgical approach for Siewert type II adenocarcinoma of the
esophagogastric junction (AEG) has not yet been agreed. Here we investigated whether the …

The importance of the proximal resection margin distance for proximal gastric adenocarcinoma: A multi‐institutional study of the US Gastric Cancer Collaborative

LM Postlewait, MH Squires III, DA Kooby… - Journal of surgical …, 2015 - Wiley Online Library
Background A 5 cm margin is advocated for distal gastric adenocarcinoma (GAC). The
optimal proximal resection margin (PM) length for proximal GAC is not established. Methods …

Current challenges in gastric cancer surgery: European perspective

K Rawicz-Pruszyński, JW van Sandick, J Mielko… - Surgical oncology, 2018 - Elsevier
Gastric cancer (GC) remains one of the most common causes of cancer death worldwide
with expected 5-year survival rates around 25% in Western countries. In order to improve …